LY4515100

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY4515100, covering 2026-03-02 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4515100 in Participants With Pain Following Third Molar Removal [Phase 2]